Skip to content

Progression of Damage in Ulcerative Colitis

Progression of Damage in Ulcerative Colitis

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03955328
Acronym
PRODUC
Enrollment
20
Registered
2019-05-20
Start date
2019-06-15
Completion date
2020-06-15
Last updated
2019-05-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ulcerative Colitis

Brief summary

The hypothesis of the study is that in ulcerative colitis repeated flares of inflammatory activity, as well as mechanisms involved in resolution of the inflammatory response, may contribute to accumulation of damage in the colon leading to functional disturbances and symptoms that affect patient's functioning. The primary objective is to determine whether ulcerative colitis induces permanent anatomical damage, by means of magnetic resonance imaging.

Interventions

DIAGNOSTIC_TESTMagnetic Resonance Imaging

A magnetic resonance imaging is perform to detect permanent anatomical damage.

Sponsors

David Garcia Cinca
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 72 Years
Healthy volunteers
No

Inclusion criteria

* Patients of both sexes aged \>18 years and \<72 years. * Ulcerative colitis diagnosed according to European Crohn's and Colitis Organization guidelines . * Ulcerative colitis in endoscopic remission as demonstrated by a recto-sigmoidoscopy/colonoscopy (defined as: Mayo Endoscopic Score 0-1; Ulcerative Colitis Endoscopic Index of Severity : bleeding 0, vascular 0-1, erosion/ulcers 0). * Normal C-reactive protein according local laboratory values. * Informed consent for participation. * Understands the language of the provided patient questionnaires.

Exclusion criteria

* Pregnant women (or pregnancy suspected). * Previous colonic surgery. * Patients receiving corticosteroids or antidiarrheal medications. * Patients with suspected or confirmed active gastrointestinal infection. * Patients with a diagnosis of other gastrointestinal disorders that may result in symptoms including, but not limited to, celiac disease, intolerance to disaccharides and pancreatic disorders. * Diabetes. * Thyroid disorders. * Liver disease. * Any other systemic disease that, according to the investigator's criteria, might influence the variables investigated. * Patients with history of colonic dysplasia.

Design outcomes

Primary

MeasureTime frameDescription
Relationship of structural changes in colon morphology and functional changes assessed by MRI with disease duration in UC patients in clinical remissionBaselineExplorative structural changes

Secondary

MeasureTime frameDescription
Patient reported outcomes on EQ-5D-5L questionnaireBaselineEQ-5D-5L questionnaire a standardized instrument for measuring generic health status, score ranges from -0.224 to 1.
Patient reported outcomes on Work Productivity and Activity questionnaireBaselineWork Productivity and Activity Impairment questionnaire is a well validated instrument to measure impairments in work and activities. Consists in 6 questions: question1: yes/no, questions 2 to 4: number of hours (count data), question 5: global rating scale, 0-10 (0 = health problems had no effect on my work, 10 = health problems completely prevented me from working), question 6: global rating scale, 0-10 (0 = health problems had no effect on my daily activities, 10 = health problems completely prevented me from doing my daily activities)
Patient reported outcomes on Disability Index questionnaireBaseline
To identify disease characteristics associated with permanent/accumulated damage disease severity with number of f the hospital admissionsBaseline
To identify disease characteristics associated with permanent/accumulated damage disease severity with dose of corticoesteroidsBaseline
To identify disease characteristics associated with permanent/accumulated damage disease severity with dose of immunosuppressantsBaseline
Patient reported outcomes on IBDQ-32 questionnaireBaselineInflammatory bowel diseases health-related quality of life index which is a questionnaire of 32 items, score ranges from 32 to 224.
To identify disease characteristics associated with permanent/accumulated damage with the disease extension at diagnosis and maximal extension of the disease at any time proctitisBaseline
To identify disease characteristics associated with permanent/accumulated damage with the disease extension at diagnosis and maximal extension of the disease at any time left colitisBaseline
To identify disease characteristics associated with permanent/accumulated damage with the disease extension at diagnosis and maximal extension of the disease at any time extensive colitisBaseline
To identify disease characteristics associated with permanent/accumulated damage with the time since the disease diagnosisBaseline
To identify disease characteristics associated with permanent/accumulated damage related to anorectal function using Cleveland Clinic Incontinence ScoreBaselineCleveland Clinic Incontinence Score is a questionnaire that reports the consistency and frequency of depositions is a 5 questions questionnaires with 7 possible answers each question.
To identify disease characteristics associated with permanent/accumulated damage disease severity with dose of biologics drugsBaseline

Countries

Spain

Contacts

Primary ContactJulia Panes, MD
jpanes@clinic.cat93.227.54.00

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026